These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 4578364)

  • 1. A cooperative trial on the primary prevention of ischaemic heart disease using clofibrate: design, methods, and progress.
    Heady JA
    Bull World Health Organ; 1973; 48(2):243-56. PubMed ID: 4578364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary prevention of ischaemic heart disease: WHO coordinated cooperative trial. A summary report.
    Bull World Health Organ; 1979; 57(5):801-5. PubMed ID: 317255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. W.H.O. cooperative trial on primary prevention of ischaemic heart disease using clofibrate to lower serum cholesterol: mortality follow-up. Report of the Committee of Principal Investigators.
    Lancet; 1980 Aug; 2(8191):379-85. PubMed ID: 6105515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trial of clofibrate in the treatment of ischaemic heart disease. Five-year study by a group of physicians of the Newcastle upon Tyne region.
    Br Med J; 1971 Dec; 4(5790):767-75. PubMed ID: 4943605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WHO cooperative trial on primary prevention of ischaemic heart disease with clofibrate to lower serum cholesterol: final mortality follow-up. Report of the Committee of Principal Investigators.
    Lancet; 1984 Sep; 2(8403):600-4. PubMed ID: 6147641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experiences of 15 years in the screening of ischaemic heart diseases and arterial hypertension].
    Santrůcek M; Geizerová H; Hejl Z; Grafnetter D
    Z Gesamte Inn Med; 1975 Nov; 30(21):709-13. PubMed ID: 1210471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ischaemic heart disease: a secondary prevention trial using clofibrate. Report by a research committee of the Scottish Society of Physicians.
    Research Committee of the Scottish Society of Physicians
    Br Med J; 1971 Dec; 4(5790):775-84. PubMed ID: 4943606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.
    Frick MH; Elo O; Haapa K; Heinonen OP; Heinsalmi P; Helo P; Huttunen JK; Kaitaniemi P; Koskinen P; Manninen V
    N Engl J Med; 1987 Nov; 317(20):1237-45. PubMed ID: 3313041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol, clofibrate and ischaemic heart disease. Facts and emotions around.
    Fejfar Z
    Cor Vasa; 1979; 21(6):377-9. PubMed ID: 397875
    [No Abstract]   [Full Text] [Related]  

  • 10. [Trials of primary prevention by diet or hypolipidemic treatment].
    Richard JL
    Arch Mal Coeur Vaiss; 1992 Sep; 85 Spec No 2():97-103. PubMed ID: 1285703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clofibrate in the treatment and prevention of ischaemic heart disease: recent trials.
    Drug Ther Bull; 1972 Aug; 10(17):65-6. PubMed ID: 4570864
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH).
    Buchwald H; Varco RL; Matts JP; Long JM; Fitch LL; Campbell GS; Pearce MB; Yellin AE; Edmiston WA; Smink RD
    N Engl J Med; 1990 Oct; 323(14):946-55. PubMed ID: 2205799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial.
    Derosa G; Cicero AE; Bertone G; Piccinni MN; Ciccarelli L; Roggeri DE
    Clin Ther; 2004 Oct; 26(10):1599-607. PubMed ID: 15598476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Primary prevention of ischemic heart disease using clofibrate. Cooperative epidemiological study].
    Geizerová H; Gyarfas I; Lamm G; Oliver M; Heady JA; Morris JN; Green K; Strasser T; Fejfar Z
    Cas Lek Cesk; 1979 Apr; 118(15):449-53. PubMed ID: 455361
    [No Abstract]   [Full Text] [Related]  

  • 15. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of ischaemic heart disease. Possibilities and problems.
    Fejfar Z; Vanĕcek R
    Rev Czech Med; 1970; 16(4):161-70. PubMed ID: 5491480
    [No Abstract]   [Full Text] [Related]  

  • 17. [The Roman coronary heart disease prevention program. Final results].
    G Ital Cardiol; 1982; 12(8):541-54. PubMed ID: 7169153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Statins in primary prevention of coronary heart disease].
    Paulweber B
    Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term therapy of ischaemic heart disease.
    Dewar HA
    Arzneimittelforschung; 1972 Oct; 22(10):1835-40. PubMed ID: 4630017
    [No Abstract]   [Full Text] [Related]  

  • 20. A clofibrate controlled trial of gemfibrozil in the treatment of hyperlipidaemias.
    Tuomilehto J; Salonen J; Kuuisto P; Virtamo J; Manninen V; Mälkönen M
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):38-40. PubMed ID: 798195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.